Internal Medicine, Hematology & Oncology · McKinney, TX
NPI
1700829249
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4510 Medical Center Dr, Suite 215
McKinney, TX, 75069
Phone (972) 542-8609
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
88,764 services
Medicare patients, 2024
510
Average age 75
Drug cost, 2024
$2.4M
1,082 prescriptions
Company payments, 2025
$2,303
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Monte F Jones was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 8,705 times for 87 patients. In total Monte F Jones billed 88,764 services in 158 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-20.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 8,705 | 87 | $0.10 | $880 |
| J1756 Injection, iron sucrose, 1 mg | Office | 6,800 | 16 | $0.18 | $1,190 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 5,250 | 16 | $0.11 | $599 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,378 | 14 | $37.18 | $88K |
| J0897 Injection, denosumab, 1 mg | Office | 1,080 | 13 | $20.82 | $22K |
| 36415 Venipuncture Blood Collection | Office | 870 | 165 | $8.65 | $7,526 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 793 | 41 | $0.09 | $71.41 |
| 80053 Clinical Chemistry | Office | 748 | 161 | $10.35 | $7,742 |
| 85025 Blood Count | Office | 747 | 160 | $7.61 | $5,685 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 490 | 15 | $0.24 | $120 |
| 99214 Office E&M - Established | Office | 449 | 158 | $91.57 | $41K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 370 | 18 | $0.71 | $262 |
| 83550 Clinical Chemistry | Office | 335 | 102 | $8.57 | $2,871 |
| 82728 Clinical Chemistry | Office | 335 | 102 | $13.36 | $4,476 |
| 83540 Clinical Chemistry | Office | 335 | 102 | $6.34 | $2,124 |
By year: 2022 $1.7M for 105,815 services; 2023 $1.9M for 123,429 services; 2024 $2.0M for 88,764 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 870 | 165 | $8.65 | $7,526 |
| 80053 Clinical Chemistry | 748 | 161 | $10.35 | $7,742 |
| 85025 Blood Count | 747 | 160 | $7.61 | $5,685 |
| 83540 Clinical Chemistry | 335 | 102 | $6.34 | $2,124 |
| 82728 Clinical Chemistry | 335 | 102 | $13.36 | $4,476 |
| 83550 Clinical Chemistry | 335 | 102 | $8.57 | $2,871 |
| 83615 Clinical Chemistry | 144 | 56 | $5.92 | $852 |
| 83735 Clinical Chemistry | 120 | 25 | $6.57 | $788 |
| 85007 Blood Count | 93 | 21 | $3.72 | $346 |
| 85027 Blood Count | 93 | 21 | $6.34 | $590 |
Medicare prescription drug claims, 2024
In 2024, the drug Monte F Jones prescribed most often to Medicare patients was Eliquis (Apixaban), with 63 prescriptions and refills. In total Monte F Jones wrote 1,082 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 63 | 106 | 19 | $60K |
| Warfarin Sodium Generic | 47 | 74 | Under 11 | $244 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 45 | 45 | 13 | $2,631 |
| Letrozole Generic | 44 | 79 | Under 11 | $606 |
| Sodium Chloride 0.9 % Sodium Chloride | 42 | 42 | Under 11 | $900 |
| Mirtazapine Generic | 36 | 40 | Under 11 | $365 |
| Levothyroxine Sodium Generic | 27 | 59 | Under 11 | $327 |
| Hydroxyurea Generic | 25 | 61 | Under 11 | $769 |
| Revlimid Lenalidomide | 25 | 25 | Under 11 | $523K |
| Gabapentin Generic | 24 | 34 | Under 11 | $236 |
| Potassium Chloride Generic | 24 | 30 | Under 11 | $221 |
| Abiraterone Acetate Generic | 23 | 23 | Under 11 | $48K |
| Anastrozole Generic | 23 | 67 | Under 11 | $338 |
| Prednisone Generic | 23 | 30 | Under 11 | $89.93 |
| Dexamethasone Generic | 21 | 27 | Under 11 | $497 |
Brand drugs: - claims; generic drugs: 747 claims; opioid claims: 103.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Monte F Jones $2,303 ($2,303 in general payments such as food, travel and fees) from 26 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $416.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $416 |
| Janssen Biotech, Inc. JNJ | 10 | $217 |
| Sobi, Inc SOBI.ST | 4 | $176 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $142 |
| Lilly USA, LLC LLY | 6 | $138 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $130 |
| Merck Sharp & Dohme LLC MRK | 5 | $124 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $101 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $97.61 |
| Gilead Sciences, Inc. GILD | 4 | $95.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.